XML 48 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Investments (Tables)
 3 Months Ended
Mar. 31, 2021
Investments [Abstract]  
Schedule of Long-term Investments The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):
March 31, 2021December 31, 2020
Respicardia Inc. (1) (2)
$21,796 $17,706 
ALung Technologies, Inc. (3)
3,000 3,000 
Ceribell, Inc.3,000 3,000 
ShiraTronics, Inc.2,045 2,045 
Noctrix Health, Inc.3,159 1,359 
MD Start II1,174 1,227 
Rainbow Medical Ltd.1,149 1,201 
Highlife S.A.S.1,113 1,163 
36,436 30,701 
Equity method investment336 393 
$36,772 $31,094 
(1)Respicardia Inc. (“Respicardia”) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $1.3 million and $0.8 million as of March 31, 2021 and December 31, 2020, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.
(2)In April 2021, Zoll Medical Corporation acquired Respicardia Inc. As a result of the acquisition we received proceeds of $23.1 million for our investment and loan receivable with carrying values of $17.7 million and $0.8 million as of December 31, 2020, respectively. The Company recorded a gain of $4.6 million during the first quarter of 2021 to adjust the investment and loans receivable to fair value, which is included in foreign exchange and other losses on the condensed consolidated statement of income (loss).
(3)ALung Technologies, Inc. (“ALung”) is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung’s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. We have a loan outstanding to ALung, with a carrying amount of $2.5 million and $2.5 million as of March 31, 2021 and December 31, 2020, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.